Select for export Effect of Psilocybin on Empathy and Moral Decision-Making. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyx047 PubMed 28637246 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2017-08-31 Pokorny T, Preller KH, Kometer M, Dziobek I, Vollenweider FX. Europe PMC Published psilocybin Receptor PharmacologyEmotional ProcessingHealthy Volunteers Other More
Select for export Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuroimage.2017.07.020 PubMed 28711736 Copy citation Copy BibTeX NeuroImage 2017-07-11 Lewis CR, Preller KH, Kraehenmann R, Michels L, Staempfli P, Vollenweider FX. Europe PMC Published psilocybin Brain ImagingPharmacologyReceptor Pharmacology Other More
Select for export Psilocybin-induced decrease in amygdala-putamen coupling during an event-related face discrimination task No abstract availability was recorded for this entry. Details DOI 10.1016/s0924-977x(16)31070-7 Copy citation Copy BibTeX European Neuropsychopharmacology 2016-09-30 O. Grimm, Rainer Krähenmann, Katrin H. Preller, Erich Seifritz, F.X. Vollenweider OpenAlex Published psilocybin Receptor Pharmacology Other More
Select for export Effects of serotonin 2A/1A receptor stimulation on social exclusion processing. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1073/pnas.1524187113 PubMed 27091970 Copy citation Copy BibTeX Proceedings of the National Academy of Sciences 2016-04-17 Preller KH, Pokorny T, Hock A, Kraehenmann R, Stämpfli P, Seifritz E Europe PMC Published psilocybin Chronic PainBrain ImagingReceptor Pharmacology Clinical Trial More
Select for export Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.euroneuro.2016.01.005 PubMed 26875114 Copy citation Copy BibTeX European Neuropsychopharmacology 2016-01-21 Pokorny T, Preller KH, Kraehenmann R, Vollenweider FX. Europe PMC Published psilocybin Receptor PharmacologyConsciousnessHealthy Volunteers Other More
Select for export P.1.i.005 The 5-HT2A/1A agonist psilocybin reduces social pain and enhances empathy in healthy volunteers No abstract availability was recorded for this entry. Details DOI 10.1016/s0924-977x(15)30364-3 Copy citation Copy BibTeX European Neuropsychopharmacology 2015-08-31 Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, Milan Scheidegger, I. Dziobek, Philipp Stämpfli OpenAlex Published psilocybin DepressionAnxietyChronic Pain Other More
Select for export The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.nicl.2015.08.009 PubMed 26909323 Copy citation Copy BibTeX NeuroImage Clinical 2015-08-21 Kraehenmann R, Schmidt A, Friston K, Preller KH, Seifritz E, Vollenweider FX. Europe PMC Published psilocybin AnxietyBrain ImagingMechanism of Action Other More
Select for export The Effect of 5-HT2A/1a Agonist Treatment On Social Cognition, Empathy, and Social Decision-making Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s0924-9338(15)30017-1 Copy citation Copy BibTeX European Psychiatry 2015-02-28 Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, I. Dziobek, Philipp Stämpfli, F.X. Vollenweider OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export P.1.g.005 Serotonergic modulation of emotion processing by the mixed 5-HT1A/2A receptor agonist psilocybin reduces amygdala activation to negative stimuli - a pharmacological fMRI study No abstract availability was recorded for this entry. Details DOI 10.1016/s0924-977x(14)70316-5 Copy citation Copy BibTeX European Neuropsychopharmacology 2014-09-24 Rainer Kraehenmann, Katrin H. Preller, Erich Seifritz, F.X. Vollenweider OpenAlex Published psilocybin Brain ImagingReceptor PharmacologyEmotional Processing Other More
Select for export Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.biopsych.2014.04.010 PubMed 24882567 Copy citation Copy BibTeX Biological Psychiatry 2014-04-25 Kraehenmann R, Preller KH, Scheidegger M, Pokorny T, Bosch OG, Seifritz E Europe PMC Published psilocybin DepressionAnxietyBrain Imaging Clinical Trial More
Select for export Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/cercor/bht178 PubMed 23861318 Copy citation Copy BibTeX Cerebral Cortex 2013-07-15 Bernasconi F, Schmidt A, Pokorny T, Kometer M, Seifritz E, Vollenweider FX. Europe PMC Published psilocybin Brain ImagingMechanism of ActionReceptor Pharmacology Observational Study More
Select for export Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1523/jneurosci.3007-12.2013 PubMed 23785166 Copy citation Copy BibTeX Journal of Neuroscience 2013-05-31 Kometer M, Schmidt A, Jäncke L, Vollenweider FX. Europe PMC Published psilocybin Receptor PharmacologyConsciousnessObservational Study Observational Study More
Select for export Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations No abstract availability was recorded for this entry. Details Copy citation Copy BibTeX Open MIND 2012-12-31 Kometer, Michael, Schmidt, André, Jäncke, Lutz OpenAlex Published psilocybin DepressionReceptor PharmacologyGenomics Other More
Select for export The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-012-2811-0 PubMed 22836372 Copy citation Copy BibTeX Psychopharmacology 2012-07-26 Schmidt A, Kometer M, Bachmann R, Seifritz E, Vollenweider F. Europe PMC Published psilocybin Receptor PharmacologyEmotional Processing Other More
Select for export Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.biopsych.2012.04.005 PubMed 22578254 Copy citation Copy BibTeX Biological Psychiatry 2012-05-09 Kometer M, Schmidt A, Bachmann R, Studerus E, Seifritz E, Vollenweider FX. Europe PMC Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/npp.2011.261 PubMed 22030715 Copy citation Copy BibTeX Unknown journal 2011-10-25 Schmidt A, Bachmann R, Kometer M, Csomor PA, Stephan KE, Seifritz E Europe PMC Published psilocybin Mechanism of ActionReceptor PharmacologyConsciousness Other More
Select for export Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/npp.2011.228 PubMed 21956447 Copy citation Copy BibTeX Neuropsychopharmacology 2011-09-27 Quednow BB, Kometer M, Geyer MA, Vollenweider FX. Europe PMC Published psilocybinpsilocin Receptor PharmacologyConsciousnessObservational Study Clinical Trial More
Select for export The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.biopsych.2010.10.002 PubMed 21126732 Copy citation Copy BibTeX Biological Psychiatry 2010-12-02 Kometer M, Cahn BR, Andel D, Carter OL, Vollenweider FX. Europe PMC Published psilocybin Receptor PharmacologyConsciousness Other More
Select for export Psilocybin slows binocular rivalry switching through serotonin modulation Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1167/6.6.43 Copy citation Copy BibTeX Journal of Vision 2010-03-18 O. Carter, John D. Pettigrew, Felix Hasler, Guy Wallis, Franz X. Vollenweider OpenAlex Published psilocybin Receptor Pharmacology Other More
Select for export Using psilocybin to investigate the relationship between attention, working memory and the serotonin 5-HT1A and 5-HT2A receptors Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1167/5.8.683 Copy citation Copy BibTeX Journal of Vision 2010-03-16 Olivia Carter, David C. Burr, John D. Pettigrew, Franz X. Vollenweider OpenAlex Published psilocybin Receptor Pharmacology Other More
Psilocybin-Research.com
Searchable psilocybin and psilocin bibliometric database.